Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
22 February 2018 Photo Sonia Small
Histories of whites beyond whiteness the focus of inaugural lecture
Prof Hendri Kroukamp, Acting Vice-Rector, Academic, Prof Neil Roos, Professor in the Centre for Africa Studies, and Prof Heidi Hudson, Acting Dean: Faculty of The Humanities.

Growing up in a small milling village on the Natal South Coast sugar belt from the mid-1960s to the early 1980s, Prof Neil Roos was exposed to poverty, privilege, liberalism, and racism. He carved out a promising academic career at the University of Natal, initially on white communists and the anomaly they represented in South African society - researching their histories in the Springbok Legion, a radical wartime kind of ‘trade union’ for soldiers.

During his doctoral work with the University of the North-West, he shifted his attention from the small number of whites who defied segregation and apartheid, to the large numbers who did not, and he began to engage with historical and comparative approaches to race. He was also interested in the sense of comradeship shown by white war veterans in the village where he lived, which included his own father, and used this interest to investigate the kinds of networks white veterans developed, as well as their role in movements like the war veterans’ Torch Commando and the Memorable Order of Tin Hats (MOTH). He used this history to show how white people were able simultaneously to ’oppose’ apartheid, yet accept its core premise of racial supremacy.

Possibility, dismay, and challenge

During his inaugural lecture on 14 February 2018 at the University of the Free State (UFS), Prof Roos addressed issues that delivered new insights under his fresh and rigorous research approach. “I intended to plot how histories of whites in South Africa have been written during several big historiographic moves, with sub-titles ‘possibility’, ‘dismay’ and ‘challenge’.” In the first section, ‘possibility’, he dealt with the vibrant 1980s-vintage South African social history, arguing that social histories of whites were at looked in a rather simplistic way. In ‘dismay’ he looked at the rise of cultural studies of whites in the new millennium which, he argued, tend to be self-absorbed, ahistorical and outside of any rigorous critique of society as a whole. In ‘challenge’ he proposed that contemporary political concerns, notably demands of the decolonisation movement, should inspire a new, activist, anti-racist history of race which draws on some of the strengths of the earlier social history movement as well as some of the techniques developed during the 1990s and the millennium to understand power, ideology and representation.

A new approach

Prof Roos proposes that histories of whites must more properly be histories of race. “This history must show the production of racial categories, reflect on the moral historiographies of being white, and the kinds of dehumanisation this demanded. It must also identify how and where whites transgressed, defied, opposed, or were simply docile. It must be emphatically anti-racist, and must absolutely avoid the possibility of apologia, of trying to gloss over or present with a human face histories of whites under colonialism, segregation and apartheid.” He also argued for an historical approach to present-day iterations of racial identity occurrences of racism, racial supremacy and racial violence.

“I intended to plot how histories of whites
in South Africa have been written during
several big historiographic moves.”

In arguing for the democratisation of studies about whites, Prof Roos argued that it is inconceivable that only whites write about histories of whites. He pointed out that black scholars bring fresh insights to the study of race, and of whites, and appealed for funding to be made available to black scholars pursuing these angles.  

Prof Roos, who is the author of Ordinary Springboks: White Servicemen and Social Justice in South Africa, 1939-1961, has held fellowships at the University of Chicago, the University of Technology Sydney, Harvard and Notre Dame. He is a professor in the International Studies Group and co-directs the Prestige Scholars’ Programme. He is the author of Whites in Apartheid Society, due for publication by Indiana University Press in 2018.

 

News Archive

Research contributes to improving quality of life for cancer patients
2016-11-21

Description: Inorganic Chemistry supervisors  Tags: Inorganic Chemistry supervisors

Inorganic Chemistry supervisors in the Radiopharmacy
Laboratory during the preparation of a typical complex
mixture to see how fast it reacts. Here are, from the left,
front: Dr Marietjie Schutte-Smith, Dr Alice Brink
(both scholars from the UFS Prestige
Scholar Programme), and Dr Truidie Venter (all three
are Thuthuka-funded researchers).
Back: Prof André Roodt and Dr Johan Venter.
Photo: Supplied

Imagine that you have been diagnosed with bone cancer and only have six months to live. You are in a wheelchair because the pain in your legs is so immense that you can’t walk anymore – similar to a mechanism eating your bones from the inside.

You are lucky though, since you could be injected with a drug to control the pain so effective that you will be able to get out of the wheelchair within a day-and-a-half and be able to walk again. Real-life incidents like these provide intense job satisfaction to Prof André Roodt, Head of Inorganic Chemistry at the University of the Free State (UFS). The research, which is conducted by the Inorganic Group at the UFS, contributes greatly to the availability of pain therapy that does not involve drugs, but improves the quality of life for cancer patients.

The research conducted by the Inorganic Group under the leadership of Prof Roodt, plays a major role in the clever design of model medicines to better detect and treat cancer.

The Department of Chemistry is one of approximately 10 institutions worldwide that conducts research on chemical mechanisms to identify and control cancer. “The fact that we are able to cooperate with the Departments of Nuclear Medicine and Medical Physics at the UFS, the Animal Research Centre, and other collaborators in South Africa and abroad, but especially the methodology we utilise to conduct research (studying the chemical manner in which drugs are absorbed in cancer as well as the time involved), enhances the possibility of making a contribution to cancer research,” says Prof Roodt.

Technique to detect cancer spots on bone
According to the professor, there are various ways of detecting cancer in the body. Cancer can, inter alia, be identified by analysing blood, X-rays (external) or through an internal technique where the patient is injected with a radioactive isotope.

Prof Roodt explains: “The doctor suspects that the patient has bone cancer and injects the person with a drug consisting of an isotope (only emits X-rays and does no damage to tissue) that is connected to a phosphonate (similar to those used for osteoporosis). Once the drug is injected, the isotope (Technetium-99m) moves to the spot on the bone where the cancer is located. The gamma rays in the isotope illuminate the area and the doctor can see exactly where treatment should be applied. The Technetium-99m has the same intensity gamma rays as normal X-rays and therefore operates the same as an internal X-ray supply.” With this technique, the doctor can see where the cancer spots are within a few hours.

The same technique can be used to identify inactive parts of the brain in Alzheimer patients, as well as areas of the heart where there is no blood supply or where the heart muscle is dead.

Therapeutic irradiation of cancer
For the treatment of pain connected with cancer, the isotope Rhenium-186 is injected. Similar to the manner in which the Technetium-99m phosphonate compound is ingested into the body, the Rhenium-186 phosphonate travels to the cancer spots. Patients thus receive therapeutic irradiation – a technique known as palliative therapy, which is excellent for treating pain. A dosage of this therapy usually lasts for about two months.

The therapy is, however, patient specific. The dosages should correspond with the occurrence and size of cancer spots in the patient’s body. First, the location of the cancer will be determined by means of a technetium scan. After that, the size of the area where the cancer occurs has to be determined. The dosage for addressing total pain distribution will be calculated according to these results.

Technique to detect cancer spots on soft tissue
Another technique to detect cancer as spots on bone or in soft tissue and organs throughout the body is by utilising a different type of irradiation, a so-called PET isotope. The Fluor-18 isotope is currently used widely, and in Pretoria a machine called a cyclotron was produced by Dr Gerdus Kemp, who is a former PhD graduate from the Inorganic Research Group. The F-18 is then hidden within a glucose molecule and a patient will be injected with the drug after being tranquillised and after the metabolism has been lowered considerably. The glucose, which is the ‘food' that cancer needs to grow, will then travel directly to the cancer area and the specific area where the cancer is located will thus be traced and ‘illuminated’ by the Fluor-18, which emits its own 'X-rays'.

In the late 80s, Prof Roodt did his own postdoctoral study on this research in the US. He started collaborating with the Department of Nuclear Medicine at the UFS in the early 90s, when he initiated testing for this research.

Through their research of more than 15 years, the Inorganic Group in the Department of Chemistry has made a major contribution to cancer research. Research on mechanisms for the detection of cancer, by designing new clever chemical agents, and the chemical ways in which these agents are taken up in the body, especially contributes to the development in terms of cancer therapy and imaging, and has been used by a number of hospitals in South Africa.

The future holds great promise
Prof Roodt and his team are already working on a bilateral study between the UFS and Kenya. It involves the linking of radio isotopes, as mentioned above, to known natural products (such as rooibos tea), which possess anti-cancer qualities.

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept